Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock
- 3 December 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 506 (1) , 83-88
- https://doi.org/10.1016/j.ejphar.2004.10.038
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A new therapeutic approach for the treatment of sepsisMedical Hypotheses, 2004
- Improvement of respiratory function by bosentan during endotoxic shock in the pigProstaglandins, Leukotrienes & Essential Fatty Acids, 2001
- Timing of endothelin and nitric oxide inhibition is crucial for survival in septic shockBritish Journal of Surgery, 2000
- Aminoguanidine attenuates endotoxin-induced mesenteric vascular hyporeactivityBritish Journal of Surgery, 2000
- The effects of bosentan, aminoguanidine and l-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic miceEuropean Journal of Pharmacology, 1999
- BLOCKADE OF TUMOR NECROSIS FACTOR REDUCES LIPOPOLYSACCHARIDE LETHALITY, BUT NOT THE LETHALITY OF CECAL LIGATION AND PUNCTUREShock, 1995
- The natural history of the systemic inflammatory response syndrome (SIRS). A prospective studyPublished by American Medical Association (AMA) ,1995
- Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassayBiochemical and Biophysical Research Communications, 1989
- Serial cardiovascular variables in survivors and nonsurvivors of human septic shockCritical Care Medicine, 1987
- Sepsis and septic shock—A review of laboratory models and a proposalJournal of Surgical Research, 1980